Emerging Fungal Infections.

Communicable Diseases, Emerging / diagnosis Fungi Humans Invasive Fungal Infections / diagnosis Mycoses / diagnosis North America Opportunistic Infections / diagnosis
Emerging fungal pathogens Emerging fungi Emerging infectious diseases Endemic fungi Opportunistic infections

Journal

Infectious disease clinics of North America
ISSN: 1557-9824
Titre abrégé: Infect Dis Clin North Am
Pays: United States
ID NLM: 8804508

Informations de publication

Date de publication:
06 2021
Historique:
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 3 3 2022
Statut: ppublish

Résumé

Various uncommon fungal pathogens have been increasingly identified as causes of disseminated and invasive fungal disease (IFD) worldwide. Growing recognition and clinical knowledge of these emerging fungal pathogens has occurred through improved molecular diagnostics, nucleic sequence databases, and taxonomic reclassification of medically significant fungi. However, emerging fungal diseases carry significant morbidity and mortality and, due to a paucity of published literature, the collective clinical experience with these fungi is often limited. In this review, we focus on unusual emerging fungal pathogens not extensively covered elsewhere in this issue of Infectious Diseases Clinics of North America.

Identifiants

DOI: 10.1016/j.idc.2021.03.014 PMID: 34016278
pubmed: 34016278
pii: S0891-5520(21)00024-6
doi: 10.1016/j.idc.2021.03.014
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-277

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Amy Spallone (A)

Baylor College of Medicine, Section of Infectious Diseases, One Baylor Plaza - BCM285, Room 672E, Houston, TX 77030, USA.

Ilan S Schwartz (IS)

Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, 1-124 Clinical Sciences Bldg, 11350-83 Avenue, Edmonton, Alberta T6G2G3, Canada. Electronic address: ilan.schwartz@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies transmissibles › Maladies transmissibles émergentes › Emerging Fungal Infections.
questionsmedicales.fr › Eucaryotes › Champignons › Emerging Fungal Infections.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Emerging Fungal Infections.
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Infections fongiques invasives › Emerging Fungal Infections.
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Emerging Fungal Infections.
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › Emerging Fungal Infections.
questionsmedicales.fr › Infection › Infections opportunistes › Emerging Fungal Infections.